-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
14 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$179.47 M
LifeStance Health Group, Inc. Insider Transactions
LifeStance Health Group, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Cipollone Paula
See Remarks |
Sell | 13,996 @ $6.93 | $96,992 | 293,562 | 03/11/2024 | 03/12/2024 | |
|
Varanakis Ann
Chief People Officer |
Sell | 15,434 @ $6.93 | $106,958 | 268,276 | 03/11/2024 | 03/12/2024 | |
|
Bourdon David
CFO |
Sell | 58,826 @ $6.93 | $407,664 | 433,856 | 03/11/2024 | 03/12/2024 | |
|
Mullins Kevin Michael
Chief Development Officer |
Sell | 115,136 @ $8.02 | $923,391 | 4,575,480 | 03/01/2024 | 03/04/2024 | |
|
Cipollone Paula
See Remarks |
Sell | 3,369 @ $7.45 | $25,099 | 290,193 | 01/03/2024 | 04/11/2024 | |
|
Mullins Kevin Michael
Chief Development Officer |
Sell | 113,334 @ $6.54 | $741,204 | 4,690,616 | 12/01/2023 | 12/04/2023 | |
|
Mullins Kevin Michael
Chief Development Officer |
Sell | 32,056 @ $6.12 | $196,183 | 4,803,950 | 11/07/2023 | 11/08/2023 | |
|
Mullins Kevin Michael
Chief Development Officer |
Sell | 300 @ $6.12 | $1,836 | 4,836,006 | 11/06/2023 | 11/08/2023 | |
|
Mullins Kevin Michael
Chief Development Officer |
Sell | 80,977 @ $6.13 | $496,389 | 4,836,306 | 11/03/2023 | 11/06/2023 | |
|
Mullins Kevin Michael
Chief Development Officer |
Sell | 113,333 @ $6.61 | $749,131 | 4,917,283 | 10/02/2023 | 10/03/2023 | |
|
Gouk Warren
Chief Administrative Officer |
Sell | 38,058 @ $8.25 | $313,979 | 5,818,204 | 09/01/2023 | 09/05/2023 | |
|
Gouk Warren
Chief Administrative Officer |
Sell | 11,966 @ $8.25 | $98,720 | 5,856,262 | 08/31/2023 | 09/05/2023 | |
|
Varanakis Ann
Chief People Officer |
Sell | 5,661 @ $7.60 | $43,024 | 168,441 | 08/24/2023 | 08/25/2023 | |
|
Mullins Kevin Michael
Chief Development Officer |
Sell | 135,400 @ $8.67 | $1.17 M | 5,030,616 | 07/06/2023 | 07/07/2023 | |
|
Mullins Kevin Michael
Chief Development Officer |
Sell | 150,000 @ $8.72 | $1.31 M | 5,166,016 | 07/05/2023 | 07/06/2023 | |
|
Mullins Kevin Michael
Chief Development Officer |
Sell | 54,600 @ $9.00 | $491,400 | 5,316,016 | 07/03/2023 | 07/06/2023 | |
|
Patel-Dunn Anisha
Chief Medical Officer |
Sell | 2,602 @ $9.24 | $24,042 | 277,055 | 06/28/2023 | 06/29/2023 | |
|
Pardo Ryan
See Remarks |
Sell | 50,136 @ $8.91 | $446,712 | 636,461 | 06/26/2023 | 06/27/2023 | |
|
Mullins Kevin Michael
Chief Development Officer |
Sell | 65,832 @ $9.02 | $593,805 | 5,370,616 | 06/23/2023 | 06/27/2023 | |
|
Gouk Warren
Chief Administrative Officer |
Sell | 57,754 @ $9.05 | $522,674 | 5,868,228 | 06/22/2023 | 06/23/2023 |
LifeStance Health Group, Inc. Frequently Asked Questions
-
Who is on LifeStance Health Group, Inc.'s Insider Roster?
The list of insiders at LifeStance Health Group, Inc. includes Mullins Kevin Michael, Cipollone Paula, Bourdon David, Varanakis Ann, Pantaleoni Pablo, Qureshi Danish J., Pardo Ryan, Burdick Kenneth A, TPG GP A, LLC, BLACK DARREN M., Silversmith Partners I GP, LLC, CRISAN JEFFREY, SUMMIT PARTNERS L P, Summit Partners Growth Equity Fund IX-A, L.P..
-
How much insider selling is happening at LifeStance Health Group, Inc.?
Insiders have sold a total of 30.37 M LifeStance Health Group, Inc. shares in the last 12 months for a total of 179.47 M sold.
-
Which LifeStance Health Group, Inc. insiders have been selling company stock?
The following insiders have sold LifeStance Health Group, Inc. shares in the last 12 months: Mullins Kevin Michael ($2.47 M), Cipollone Paula ($484,658), Bourdon David ($407,664), Varanakis Ann ($106,958), Pantaleoni Pablo ($352,723), Qureshi Danish J. ($1.49 M), Pardo Ryan ($639,736), Burdick Kenneth A ($1.35 M), TPG GP A, LLC ($85.84 M), BLACK DARREN M. ($22.40 M), Silversmith Partners I GP, LLC ($9.57 M), CRISAN JEFFREY ($9.57 M), SUMMIT PARTNERS L P ($22.40 M), Summit Partners Growth Equity Fund IX-A, L.P. ($22.40 M),